Tamoxifen Ebewe Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Tamoxifen

Indications/Uses

Breast cancer & endometrium carcinoma in women. Adjuvant therapy for women w/ positive axillary node breast cancer. Metastatic breast cancer in men & women.

Click to view Tamoxifen Ebewe detailed prescribing information

Dosage/Direction for Use

20 mg daily. Max: 40 mg daily. Patient w/ advanced disease 30 or 40 mg daily.

Click to view Tamoxifen Ebewe detailed prescribing information

Overdosage

View Tamoxifen Ebewe overdosage for action to be taken in the event of an overdose.

Administration

May be taken with or without food.

Contraindications

Hypersensitivity. Severe thrombocytopenia, leukopenia or hypercalcaemia. Pregnancy.

Click to view Tamoxifen Ebewe detailed prescribing information

Special Precautions

Discontinue if atypical hyperplasia develops. Increased incidence of endometrial changes including hyperplasia, polyps & cancer. Patients w/ liver & kidney disease, DM, history of thromboembolic disease, visual disturbances. Perform gynaecological & internal exams prior to & at least 6-mthly intervals during treatment; ophth exam; lung & bone x-ray & liver ultrasound to see possible early metastasis. Contraceptive measures should be taken at least 3 mth after end of therapy. Not recommended during lactation.

Click to view Tamoxifen Ebewe detailed prescribing information

Use In Pregnancy & Lactation

Click to view Tamoxifen Ebewe detailed prescribing information

Adverse Reactions

Hot flushes, abnormal vag bleeding including menstrual irregularities, vag discharge & pruritus vulvae; fluid retention, nausea, vomiting. Impotence or loss of libido in males. Leukopenia, thrombocytopenia. Ophth disturbances, hypersensitivity reactions.

Click to view Tamoxifen Ebewe detailed prescribing information

Drug Interactions

Oestrogen-containing hormone medications may decrease both effects. May increase anticoagulant effect of coumarin-type anticoagulants. May increase bleeding tendency w/ thrombocyte aggregation inhibitors. More frequent thromboembolic events w/ cytotoxic agents. Elevated serum w/ bromocriptine.

Click to view Tamoxifen Ebewe detailed prescribing information

Caution For Usage

For caution against possible variation of physical aspect of medicine... Click to view Tamoxifen Ebewe detailed prescribing information

Storage

View Tamoxifen Ebewe storage conditions for details to ensure optimal shelf-life.

Description

View Tamoxifen Ebewe description for details of the chemical structure and excipients (inactive components).

Action

View Tamoxifen Ebewe mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Cancer Hormone Therapy

ATC Classification

L02BA01 - tamoxifen ; Belongs to the class of anti-estrogens. Used in treatment of neoplastic diseases.

Regulatory Classification

POM

Presentation/Packing

Form

Tamoxifen Ebewe tab 20 mg

Packing/Price

30's

Tamoxifen Ebewe

tamoxifen

Manufacturer:

EBEWE Pharma

Distributor:

Maxxcare

Marketer:

Mega Lifesciences